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The underlying cause of aging remains one of the central mysteries of biology. Recent studies in
several different systems suggest that not only may the rate of aging be modified by environmental
and genetic factors, but also that the aging clock can be reversed, restoring characteristics of
youthfulness to aged cells and tissues. This Review focuses on the emerging biology of rejuvena-
tion through the lens of epigenetic reprogramming. By defining youthfulness and senescence as
epigenetic states, a framework for asking new questions about the aging process emerges.Introduction
The inexorable tolls of aging are evident in almost all living
beings. From the onset of reproductive maturity, organismal
aging is generally characterized by a decline in fecundity, an
increased susceptibility to disease and tissue dysfunction, and
increased risk of mortality (Kirkwood, 2005; Hayflick, 2007; Kirk-
wood and Shanley, 2010). Aging is associated with a gradual
loss of homeostatic mechanisms that maintain the structure
and function of adult tissues. Amajor challenge of aging research
has been to distinguish the causes of cell and tissue aging from
themyriad of changes that accompany it. One of the hallmarks of
cellular aging is an accumulation of damaged macromolecules
such as DNA, proteins, and lipids. These become chemically
modified by reactive molecules, such as free radicals, that are
generated during normal cellular metabolism and whose
production increases with age (Haigis and Yankner, 2010).
DNA damagemay lead to cellular dysfunction directly by altering
the expression of specific genes or indirectly as result of cellular
responses to damage that can alter gene expression more glob-
ally (Seviour and Lin, 2010; Campisi and Vijg, 2009). Damage to
proteins may independently contribute to cellular aging if mis-
folded or damaged proteins are replaced more slowly than
they are generated, especially when they form stable aggregates
that are not degraded by the cell (Koga et al., 2011). Such ‘‘pro-
teotoxicity’’ has been postulated to underlie many age-related
diseases and may also be an important part of normal cellular
aging (Douglas and Dillin, 2010).
The consequences of age-related changes to the macromo-
lecular components of a cell, particularly for long-lived postmi-
totic cells like neurons and myofibers, lead to gradual loss of
normal structure and function—so-called ‘‘chronological aging,’’
marked simply by the passage of time. For continuously dividing
cells, like those of the epithelia of the skin or gut, there is the46 Cell 148, January 20, 2012 ª2012 Elsevier Inc.added challenge of ‘‘replicative aging,’’ referring to the accumu-
lation of cellular damage, such as telomere shortening and repli-
cation-associated DNA mutations, that occurs during the
process of cell division (Rando, 2006; Liu and Rando, 2011).
This is particularly relevant for adult stem cells because they
divide throughout the life of the individual and therefore experi-
ence both chronological and replicative aging (Charville and
Rando, 2011). As the burden of mutations increases with age,
the likelihood that a cell will undergo apoptosis, malignant trans-
formation, or senescence, which for diving cells means irrevers-
ible cell-cycle arrest (Kuilman et al., 2010), also increases.
Although cellular function invariably declines with age, it may
be that some of the changes, for example senescence and
apoptosis, are actually adaptive in order to prevent cellular trans-
formations such as metaplasia or neoplasia that may result from
age-related genomic instability.
Despite the fact that aging appears to be inexorable, with the
ultimate result being the death of the organism, it is incontrovert-
ible that life span itself can be experimentally manipulated. An
unlimited number of genetic defects and environmental chal-
lenges that may have no relation to the normal drivers of aging
can shorten life span, but both genetic and environmental inter-
ventions have been shown to extend the life span of model
organisms such as the nematode worm Caenorhabditis elegans
(C. elegans), the fruit flyDrosophila melanogaster, and laboratory
mice (Kenyon, 2010; Fontana et al., 2010). For example, muta-
tions in individual genes in the insulin/insulin-like growth factor
signaling pathway, in the pathways of protein translation
involving the enzyme mammalian target of rapamycin (mTOR),
and in energy-sensing pathways involving AMPK have all been
shown to extend life span in model organisms (Kimura et al.,
1997; Kapahi et al., 2004; Apfeld et al., 2004). In terms of environ-
mental influences that can extend life span, none is better
studied or more broadly effective, from C. elegans to mammals,
than dietary restriction (Fontana et al., 2010). However, extend-
ing life span is not equivalent to delaying aging. Interventions
may prevent common causes of death (for example, improved
safety features to prevent automobile accidents as a sociological
intervention or treatment of acute infectious illnesses as
a medical intervention), without changing the fundamental rate
of organismal aging. Nevertheless, it does seem that many
so-called ‘‘longevity genes,’’ as well as dietary restriction,
appear to extend not only life span, but also ‘‘health span’’
(Kauffman et al., 2010; Luo et al., 2010). In that regard, it does
appear that it is possible to experimentally slow the rate of aging.
Still, in each case, aging does continue on as if there is some
clock that is driving individual aging, ticking relentlessly toward
old age and death.
Though these examples support the notion that the process of
aging can be slowed, there are also clear examples in nature
when the aging clock appears to be temporarily arrested. The
average life expectancy of C. elegans is about 2 weeks.
However, under specific conditions such as food scarcity, the
developing larvae can adopt an alternate fate, called a dauer
stage, that does not feed and is metabolically relatively inactive
(Fielenbach and Antebi, 2008). Dauer larva can survive for
months, effectively prolonging the life span of the worm by an
order of magnitude. Such diapauses are common in nature
and reflect evolutionarily conserved responses to periods of
adverse environmental conditions when survival is at stake.
Even more dramatic examples of prolonged periods of survival
in an arrested state come from the study of seeds and spores.
Viable seeds capable of germination and growth have been
obtained from excavations and dated as being 2,000 years old
(Sallon et al., 2008). Viable bacterial spores have been found
preserved in amber for 25–30 million years (Cano and Borucki,
1995) and preserved in salt crystals for 250 million years (Vree-
land et al., 2000). Such examples reflect the remarkable survival
ability of life forms under extreme conditions. These forms of life
exist in suspended states that appear to arrest fundamental
biological processes, including any aging that may accompany
those processes, uncoupling the process of biological aging
from chronological aging measured by the passage of time.
However, is there reason to hypothesize that it is possible not
only to arrest, but to reverse the aging clock?
Resetting of the Aging Clock
Despite the apparently unidirectional and inexorable process of
aging of individual metazoans, the ability of the aging clock to be
not only halted but reversed, or ‘‘reset to zero,’’ is so deeply
embedded in the nature of life itself that it should not be
surprising. Yet the process appears so mysterious that it is diffi-
cult to reconcile with concepts of individual aging. We are refer-
ring here to the resetting of the aging clock that comeswith every
fertilization event, giving rise to a zygote that will ultimately
mature into an adult member of the species. For humans, this
involves the fusion of two cells, a sperm and an egg, each of
whose chronological age is measured in decades, to form
a single cell that somehow erases any trace of the age of the
parental cells. This resetting, or ‘‘reprogramming,’’ of the zygotic
nucleus, rewinding the aging clock to begin anew, ismediated byfactors in the oocyte cytoplasm that are at the heart of this
mystery of rejuvenation. Granted, though the ‘‘biological age’’
of germ cells may differ from the biological age of other cells in
the soma, there is no evidence that germ cells exist in any kind
of diapause or metabolic arrest, completely resistant to the
myriad of age-related changes that occur in cells over time.
Therefore, the erasure of any manifestations of germ cell aging
is central to the survival of the species. Were it not for this reset-
ting of the aging clock, species would age with each generation
and ultimately fail to propagate as the germline increasingly bore
the burden of the effects of aging that occur during maturation to
reproductive maturity.
The reprogramming process that is so central to fertilization,
even though poorly understood, was exploited in the very
earliest cloning experiments using somatic cell nuclear transfer
(SCNT), in which the nucleus of a mature somatic cell is trans-
ferred to an enucleated oocyte (Briggs and King, 1952). The
pioneering work of Dr. John Gurdon in this area showed for the
first time that differentiated nuclei from tadpole intestinal or
muscle cells could be transferred into enucleated Xenopus
eggs and give rise to mature and fertile male and female frogs
(Gurdon, 1962). Like the fused nucleus of the sperm and egg
during fertilization, the somatic nucleus is reprogrammed by
the oocyte cytoplasm to allow the development of a new
member of the species, resetting any hallmarks of aging that
the somatic nucleus bore upon transplantation. Importantly,
these studies challenged the dogma at the time that the process
of aging and differentiation froma single fertilized egg to amature
adult involved the loss of genetic material, which would in
essence be an irreversible process rendering the resulting nuclei
incapable of recapitulating the embryological developmental
program. This early work demonstrated unequivocally that the
full battery of genetic material present at fertilization and neces-
sary to give rise to an adult organism is maintained in cells
through development and maturation to adulthood. They also
showed that the nuclei of adult somatic cells, just like that of
the genetic material in the adult sperm and egg, can be appar-
ently rejuvenated and can have pluripotency restored in the
context of the oocyte cytoplasm.
The fact that the nuclei were capable of giving rise to viable
embryos that were themselves capable of developing into fertile
adults and did not exhibit premature aging is evidence that the
chronological age of the donor nuclei had been reset. Thus,
just like the example of fertilization, SCNT appears to be capable
of resetting the aging clock for propagating a species. Whether
there are any age-related alterations of the transplanted nucleus,
for example in the genome, that were not erased by the process
of SCNT cannot be ruled out and raises the fundamental ques-
tion of how to define a young or old nucleus on a molecular level
(this issue is considered in a later section). SCNT is, of course,
also the process that gave rise to the first cloned mammal, Dolly
the sheep (Campbell et al., 1996), which led to an explosion of
research in cloning. In those studies, nuclei from different devel-
opmental and adult tissues were used and yielded viable lambs.
Dolly actually died young (at 6 years of age as opposed to the
typical life span of about 12 years for her breed). But the cause
of death was a viral illness, not a premature aging syndrome.
Dolly was fertile and gave birth to numerous offspring. Still,Cell 148, January 20, 2012 ª2012 Elsevier Inc. 47
whether animals that are cloned from adult nuclei by SCNT are
normal in terms of health and longevity remains to be fully deter-
mined. The majority of cloned animals often die in early develop-
ment or display growth defects postnatally, possibly due to
incomplete epigenetic reprogramming (Rideout et al., 2001)
but also possibly due to genomic changes in the donor nucleus
or technical limitations associated with the SCNT process. Still,
SCNT demonstrates the remarkable ability of the oocyte cyto-
plasm to reprogram the donor nucleus, not only erasingmanifes-
tations of differentiation, but also resetting the chronological age.
Recent advances in stem cell biology have begun to unlock
the molecular secrets behind these reprogramming events that
occur during fertilization and SCNT. Specifically, these advances
refer to the discovery of the process to create induced pluripo-
tent stem cells (iPSCs) (Takahashi and Yamanaka, 2006), by
which a variety of terminally differentiated adult cells, initially
from mouse and human and more recently from other species,
can be converted to pluripotent stem cells by the introduction
of a small number of transcription factors such as Oct4, Sox2,
and Klf4 (Stadtfeld and Hochedlinger, 2010). Pluripotency is
a cellular property defined as the ability to give rise to differenti-
ated cells in all three germ layers of the embryo: the ectoderm,
the endoderm, and the mesoderm. In that regard, iPSCs
resemble embryonic stem cells (ESCs), pluripotent stem cells
derived from the inner cell mass of an early embryo and able to
both give rise to any cell type in the body and support complete
fetal development (Rossant, 2001). Likewise, iPSCs can
generate an entire mouse embryo, including the germline (Stadt-
feld and Hochedlinger, 2010). Indeed, the ability of a limited
number of transcription factors to effect iPSC reprogramming
stems from their key roles in the ESC gene expression program
(Young, 2011). Furthermore, detailed analyses of multiple iPSC
lines have shown that their global gene expression programs
and chromatin states are remarkably similar to those of ESCs,
though not equivalent (Loh and Lim, 2010; Ouyang et al., 2010).
One possible rejuvenating consequence of iPSC reprogram-
ming is reactivation of the expression of telomerase (Mario´n
and Blasco, 2010), the enzyme responsible for maintaining telo-
mere length and long-term self-renewal potential in ESCs (Zeng,
2007). Genetic defects in components of the telomerase
complex may prevent the restoration of telomere length and
full telomerase activity during iPSC reprogramming in some
conditions but not others (Agarwal et al., 2010; Batista et al.,
2011). Nevertheless, the fact that differentiated adult cells can
be directly reprogrammed to iPSCs by known factors rather
than by the complex oocyte cytoplasm has generated yet
another paradigm whereby the aging clock is reset. However,
just like SCNT, the process of generating iPSCs is inefficient,
and the vast majority of cells fail to attain the status of a pluripo-
tent stem cell capable of giving rise to a new, fertile organism
(Stadtfeld and Hochedlinger, 2010). There is clearly an important
process of selection of those cells that aremost fit and amenable
to reprogramming, although the molecular bases of this fitness
test are only now beginning to be revealed.
Although we describe each of these processes in the context
of resetting of the aging clock, the major emphasis of research in
the field of reprogramming is, in fact, reversal of the differentia-
tion program and the attainment of a pluripotent state (Hanna48 Cell 148, January 20, 2012 ª2012 Elsevier Inc.et al., 2010), not the reversal of aging. In all of the examples pre-
sented, rewinding of the aging clock is coupled to the reversal of
the differentiation program. The cell, whether a sperm or egg in
the case of fertilization or an adult somatic cell (or its nucleus)
in the case of SCNT or iPSC generation, not only rejuvenates,
but also completely loses its differentiated characteristics.
Indeed, this ‘‘dedifferentiation’’ is at the essence of the process
of fertilization, as well as the ability of either SCNT or iPSC gener-
ation to create ESC-like cells. In each case, the cell (or its
nucleus) ceases to maintain its identity as a particular differenti-
ated cell type and, instead, adopts a pluripotent state coupled to
the adoption of amore youthful state. However, to restore youth-
ful properties to aged tissues for therapeutic purposes, for
example to improve wound healing in aged skin or to improve
cardiac function in the aged heart, the ideal would be to reset
the aging clock but to leave the differentiation program
untouched. Converting aged cardiomyocytes to pluripotent
stem cells might yield no beneficial effect and might, in fact,
have profound detrimental consequences. One of the major
limitations of ESCs and iPSCs therapeutically is the fact that,
upon transplantation, they have the propensity to form tera-
tomas, tumors that have the features of all three germ layers
(Takahashi and Yamanaka, 2006). By contrast, converting
aged cardiomyocytes into young cardiomyocytes, without going
through a pluripotent state, could improve cardiac function
directly. This raises the fundamental question: Is it possible to
uncouple the resetting of the aging clock from the resetting of
the differentiation program?
Rejuvenation without Dedifferentiation
Recent studies have begun to test the potential of different inter-
ventions to restore youthfulness to aged cells or tissues.
Although not specifically designed to address the question
posed above as to whether cell or tissue rejuvenation can be
achieved without dedifferentiation, evidence suggests that it
may be possible to uncouple the processes that ‘‘maintain’’
the aged state (a concept that we will return to) from those that
maintain the differentiated state. The following are three exam-
ples of apparently rejuvenating interventions—one environ-
mental, one genetic, and one pharmacologic—that result in
apparently more youthful states of aged cells that retain their
differentiated states.
To test whether cells and tissues from an old animal can be
restored to a more youthful state by environmental exposure,
experimental approaches have included heterochronic (i.e.,
young-to-old or old-to-young) transplantations and hetero-
chronic parabiosis, whereby the systemic circulations of two
animals are joined together (Bunster and Meyer, 1933). Histori-
cally, this has been used to explore age-related physiological
and pathological changes (Finerty, 1952; Tauchi and Hasegawa,
1977) and even longevity (McCay et al., 1957). Recently, hetero-
chronic parabiosis (Figure 1) has been used to test whether
tissue-specific stem cells (i.e., stem cells that are not pluripotent
but are already committed to a specific germ layer or even
a specific tissue) from old mice could be rejuvenated by expo-
sure to a young environment (Conboy et al., 2005). Not only
did the aged cells in muscle and liver adopt amore youthful func-
tional phenotype, but the molecular signatures of aging were
Figure 1. Rejuvenation without Dedifferentiation
With age, distinct changes are evident in any mammalian tissue examined,
such as impaired regenerative responses in skeletal muscle, thinning of the
skin epithelium, and hypercellularity of the bone marrow. Different interven-restored to a more youthful state (Conboy et al., 2005). Likewise,
the young stem cells adopt a more aged molecular and func-
tional state in these heterochronic parabiotic pairings (Brack
et al., 2007; Villeda et al., 2011), demonstrating that the systemic
environment is a powerful determinant of the ‘‘age’’ of cells in an
organism (determined functionally, not chronologically). It may
be that systemic influences are mediated by different signaling
pathways in different tissues, but studies in muscle suggest
that the manifestations of age are due to changes in the
Notch-, Wnt-, and TGF-b-signaling pathways (Conboy et al.,
2005; Brack et al., 2007; Carlson et al., 2008) and that the rejuve-
nating effects of heterochronic parabiosis may be due to resto-
ration of a more youthful systemic milieu in terms of protein
components, particularly chemokines and cytokines, in the
blood and tissues (Villeda et al., 2011). In addition to illuminating
the influence of the systemic environment on cellular function,
such heterochronic studies emphasize the potential role of envi-
ronmental factors in rejuvenating aged cells.
Molecular signatures of aging have been directly tested as
determinants of the aged state by genetically manipulating
specific biochemical pathways. A recent example demonstrates
the power of transcriptional profiling and bioinformatic analysis
to reveal an aging signature that can be genetically engineered
to reflect a more youthful state (Adler et al., 2007). In a compar-
ison of old and young tissues frommice and humans, old tissues
were found to express at significantly higher levels a set of genes
that contained sequences in their 50 regulatory regions, indica-
tive of regulation by the NF-kB-signaling pathway (Adler et al.,
2007). This led to the hypothesis that an increase in NF-kB
activity was necessary to maintain the aged phenotype, which
introduced the novel concept that the aged state, much like
the differentiated state, might require active maintenance. The
direct test of this involved the generation of a transgenic mouse
strain in which NF-kB could be conditionally inhibited in the skin.
After these mice were allowed to age normally, expression of the
NF-kB inhibitor resulted in the skin rapidly reverting to a more
youthful state and manifesting the molecular signature of youth-
fulness (Adler et al., 2007). Markers of cell senescence, such as
the cell-cycle inhibitor protein p16, disappeared, and skin
progenitor cells regained their proliferative activity, rebuilding
atrophic skin to a youthful depth while maintaining the rigors of
stratification and differentiation (Figure 1).
A third example illustrates that pharmacological targeting of
pathways that have been implicated in promoting aging may
also restore youthfulness at cellular and biochemical levels.
Among the key regulators associated with interventions that
extend life span is the enzyme mTOR, which senses cellular
nutrient levels and in turn regulates rates of protein synthesistions have been shown to restore youthful function in each of these tissues in
aged mice. Heterochronic parabiosis (or inhibition of Wnt or TGF-b signaling)
enhances aged muscle regeneration, increasing the formation of new muscle
and reducing fibrosis (left). Inhibition of NF-kB signaling restores the youthful
skin phenotype, expanding the thickness of the epithelium (middle). Inhibition
of mTOR signaling with rapamycin restores the youthful state of the hemato-
poietic system, reducing the hypercellularity that characterizes the aged tissue
(right). In each case, not only are the youthful cell and tissue phenotypes
restored, but the molecular signatures of youthfulness are also induced in the
aged cells during the period of treatment.
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and energy utilization. Notably, administration of rapamycin, an
mTOR inhibitor, starting at midlife can extend the life span of
mice, suggesting that aging can be delayed or reversed in
multiple cell types (Harrison et al., 2009). In the hematopoietic
system, aging is associated with an increase in mTOR activation
in stem cells and progenitors (Chen et al., 2009). Administration
of rapamycin to old mice to inhibit mTOR not only limited the
normal age-related increases in hematopoietic stem cells and
biomarkers of aging in those cells, but also enhanced the perfor-
mance of the stem cells to become as effective as young stem
cells in heterochronic transplantation experiments (Chen et al.,
2009) (Figure 1).
Together, these kinds of studies indicate that it may be
possible to uncouple the aging clock from the differentiation
program. In each case, the old cells are induced to adopt a
more youthful phenotype without losing their differentiated
characteristics; the muscle stem cells, the epithelial cells, and
the hematopoietic stem cells all maintained their individual
identities but functioned as if there had been a partial rewinding
of the aging clock. Intriguingly, the reactivation of telomerase in
adult tissue stem cells with experimentally shortened telomeres
is sufficient to reverse degenerative pathologies—some typical
of aged tissues—in multiple organs (Jaskelioff et al., 2011). As
with the rejuvenating interventions described above, there
does not appear to be any loss of differentiated phenotypes. In
what ways are all of these processes and their resulting cellular
states different from reprogramming that occurs with fertiliza-
tion, SCNT, and iPSC generation, in which there is both dediffer-
entiation and rejuvenation? To address that question, it is first
necessary to understand the molecular mechanisms that
underlie reprogramming to the pluripotent state.
Epigenetics and Epigenetic Reprogramming
The mechanisms that underlie reprogramming of nuclei and
erasure of the differentiation program during fertilization,
SCNT, and iPSC generation are at the core of the field of epige-
netics. Virtually all cells in a multicellular organism have the same
DNA but can turn on different genes as a result of epigenetic
mechanisms, thus allowing genetically identical cells to adopt
divergent fates such as hepatocytes in the liver, neurons in the
brain, or macrophages in the blood. Epigenetic regulation can
occur by the direct methylation and demethylation of DNA
bases, so called ‘‘cis-epigenetics’’ (Bonasio et al., 2010). The
extent of cytosine methylation of the 50 regulatory region is an
important determinant of the expression of a gene, with high
levels of methylation associated with repression. Regulation of
chromatin adds another level of epigenetic complexity. Histones
come in several variants and can be altered by a number ofmodi-
fications, including methylation and acetylation. Specific histone
modifications are associated with expressed genes and others
with repressed genes (Rando and Chang, 2009). For example,
genes that are enriched for histone 3 trimethylated at lysine 4
(H3K4me3) tend to be expressed. By contrast, genes that are
enriched for histone 3 trimethylated at lysine 27 (H3K27me3)
tend to be repressed. Histone acetylation is generally associated
with gene expression (Wang et al., 2008a). Finally, regulation of
gene expression can also occur by ‘‘trans-epigenetics’’ (Bonasio
et al., 2010), in which proteins and RNAs influence gene expres-50 Cell 148, January 20, 2012 ª2012 Elsevier Inc.sion and repression. Stable transcription factor networks are an
example of trans-epigenetics (Young, 2011). Clearly, enzymes
that modify DNA and histones (methyltransferases, demethy-
lases, acetyltransferases, deacetylases) are central epigenetic
regulatory mechanisms (Rando and Chang, 2009).
The essence of epigenetics is not only the establishment, but
also themaintenance, of a biological state, as cells need tomain-
tain their identity over time through rounds of cell division and in
response to a myriad of environmental influences. The robust-
ness of an epigenetic state is referred to as ‘‘canalization’’
(Rando and Verstrepen, 2007), the concept of a particular state
being buffered against change (by being ‘‘canalized’’); the
more canalized an epigenetic state is, the more stable it is over
time, during cell division, and in the face of environmental
changes. Clearly, the differentiated state of cells in the adult
organism is highly canalized.
Although epigeneticmechanisms confer stability to cell states,
early SCNT experiments clearly demonstrated that epigenetic
states are plastic and reversible. Epigenetic reprogramming,
like epigenetics itself, refers to changes in the stable transcrip-
tional profile of a cell and changes in the very nature of that
cell without changes in DNA sequences. Chromatin states can
be erased if the modifications on DNA and histones that define
them are altered. This can occur in a passive manner through
successive cell divisions if the enzymes that modify DNA and
histones fail to reinforce the modifications on newly synthesized
chromatin during and after DNA replication (Rando and Chang,
2009). The passive erasure of chromatin states can be gradual
and may require multiple rounds of cell division to ‘‘dilute out’’
the original pattern (Dodd et al., 2007). The phenomenon of
position effect variegation (PEV) provides a prime example of
this principle (Girton and Johansen, 2008). PEV can occur
when a reporter gene is inserted near transcriptionally silent
heterochromatin; the silent state can spread over to the reporter
gene and be passed on to progeny cells. The strength of epige-
netic silencing can be read out by the degree of variegation
among cell clones. Strong silencing leads to uniform, large
clones, whereas weak silencing leads to a salt-and-pepper
intermingling of small clones as evidence of transcriptional reac-
tivation after a few cell divisions.
This passive mechanism of epigenetic reprogramming can be
viewed as a natural time-keeping strategy; a new biological state
will emerge over time after a certain number of cell divisions via
stochastic loss or degradation of epigenetic information (Rando
and Verstrepen, 2007). The requirement for multiple rounds of
cell division makes this mechanism particularly relevant to
tissue-specific stem cells, which in many adult tissues are
capable of multiple rounds of cell division throughout the life
span of the organism. Passive epigenetic reprogramming may
also be naturally coupled to environmental conditions. For
instance, if tissue injury leads to compensatory cell divisions,
then the process of regeneration creates a situation in which
passive epigenetic reprogramming can be revealed. Indeed,
Drosophila imaginal disc cells can change their positional iden-
tity, changing from a leg disc cell to a wing disc cell, for example,
upon tissue fragmentation and regeneration. This process
involves weakening of epigenetic silencing by passive mecha-
nisms (Lee et al., 2005). Alternatively, chromatin states can be
reprogrammed actively by regulated relocalization of one or
more regulatory enzymes. Many chromatin modification
enzymes do not have intrinsic DNA binding specificity and
need to be recruited to their target genes on chromatin. These
recruitment mechanisms include sequence-specific transcrip-
tion factors, pre-existing chromatin marks that serve as docking
sites, and both long and short noncoding RNAs (Ruthenburg
et al., 2007; Bonasio et al., 2010; Hung and Chang, 2010).
Thus, a dynamic steady state between both passive and active
mechanisms underlies the apparent stability, as well as potential
for reprogramming, of the epigenetic landscape.
The processes described above leading to dedifferentiation
are prime examples of active epigenetic reprogramming. During
early development, two major waves of epigenetic reprogram-
ming occur (Feng et al., 2010). After fertilization, the zygotic
genome undergoes dramatic epigenetic reprogramming. DNA
methylation is erased wholesale and later re-established (Feng
et al., 2010; Meissner, 2010), and histone modifications are
also extensively reorganized. A second wave of DNA demethyla-
tion and resetting of imprinting marks occurs in the gonad of the
zygote, when the primordial germ cells are produced. Many of
the epigenetic changes that occur in the former setting—in the
early zygote—are mimicked by iPS reprogramming (Mikkelsen
et al., 2008). The embryonic genome is believed to be transcrip-
tionally inactive until maternal zygotic transition. This transition
also corresponds to a period of enrichment of H3K4me3 on
specific gene loci and the formation of so-called bivalent
domains, enriched for both H3K27me3 (repressive) and
H3K4me3 (active) marks and therefore poised for future activa-
tion (Vastenhouw et al., 2010). This choreography of chromatin
marks also occurs on enhancers, which are typically marked
by histone H3 monomethylated on lysine 4 (H3K4me1). The
transition of enhancers from an inactive to an active state, for
example during ESC differentiation, is marked by the change
of histone H3 lysine 27 from trimethylation (H3K27me3) to
acetylation (H3K27ac) (Rada-Iglesias et al., 2011; Creyghton
et al., 2010).
The potency and efficacy of reprogramming conditions are
revealed by SCNT and cell fusion (including fertilization) studies,
in which a ‘‘donor’’ nucleus is suddenly exposed to a different
complement of trans-acting regulatory factors. The expression
pattern of some genes of transferred or fused nuclei may be
reprogrammed to resemble that of the host cell, but some genes
retain the pattern of expression of the donor nucleus. DNAmeth-
ylation is strongly associated with the loci that resist reprogram-
ming (Lee et al., 2009a, 2009b). In addition, an apparent
hierarchy of cell fate dominance can be derived by pair-wise
fusion of different cell types (Terranova et al., 2006; Piccolo
et al., 2011). The basis of the hierarchy of cell fate dominance
is not known, but ESCs are at the top of this hierarchy because
they can reprogram most fusion partners to transcribe an
ESC-like gene expression program (Cowan et al., 2005; Tada
et al., 2001). One potential explanation for the success of iPS
reprogramming is that the ESC state is stabilized by a positive
feedback loop. The core pluripotency transcription factors co-
occupy their own and each other’s enhancer elements, providing
a strong positive feedback for maintenance of the ESC state
(trans-epigenetics). Moreover, these factors directly bind toand activate genes important for ESC pluripotency and can
also repress genes by controlling their epigenetic state. In
ESCs, for example, Oct4, Sox2, and Nanog repress the long
noncoding RNA Xist, the expression of which is necessary and
sufficient to mark one of two X chromosomes in female cells
for transcriptional silencing. Downregulation of the core tran-
scription factors allows derepression of Xist and subsequent
X chromosome inactivation in conjunction with ESC differentia-
tion (Donohoe et al., 2009; Navarro et al., 2008).
One characteristic of reprogramming associated with reset-
ting of the aging clock is low efficiency. Typical iPSC reprogram-
ming yields < 1% conversion rate, and even among iPSC
colonies, there is considerable heterogeneity (Stadtfeld and
Hochedlinger, 2010). Thus, an important feature of iPS reprog-
ramming is a selection among the starting cell population,
allowing for only the most capable cells to emerge. The molec-
ular determinants of fitness remain unclear; however, p16 and
p53 proteins, both of which are associated with senescent or
damaged cells, are both strong barriers to iPSC formation
(Krizhanovsky and Lowe, 2009). This feature of iPSC formation,
effectively a form of Darwinian selection, is likely also to account
for the low efficiency of successful SCNT and may be an impor-
tant determinant of successful fertilizations, in each case
providing quality control and allowing only the most robust cells
of highest integrity to progress.
Aging and Epigenetics
Is it reasonable to consider aging to be comparable to differen-
tiation in terms of epigenetic determination? Although many
parallels exist, an important difference is that differentiation
occurs without any specific change in the genome, whereas
aging is associated with (and may be due at least in part to)
the accumulation of nuclear and mitochondrial DNA mutations
(Garinis et al., 2008). The irreversibility of somatic mutations
that accompany aging of replicative and postmitotic cells means
that ‘‘rejuvenated’’ cells may not necessarily be identical to
young cells, as mentioned with regard to SCNT. However,
although the accumulation of nuclear and mitochondrial DNA
mutations has clearly been correlated with aging (Vijg et al.,
2005; Herbst et al., 2007) and increasing the burden ofmitochon-
drial DNAmutations can shorten life span (Trifunovic et al., 2004),
there is no direct evidence that DNA mutations are the proximal
cause of cellular aging. Specifically, no experiment has demon-
strated that a reduction in DNA mutations leads to an extension
of life span. As such, there is currently much interest in the role of
epigenetic processes as mediators of the aging process (Ober-
doerffer and Sinclair, 2007; Campisi and Vijg, 2009). The obser-
vations that the aging clock can be halted in theC. elegans dauer
state, reset at fertilization, and potentially rewound by the envi-
ronmental influences described above suggest strongly that
the manifestations, and possibly the causes, of aging may be
largely epigenetic. The hypothesis is further supported by the
recent finding of transgenerational epigenetic inheritance of
extended life span in C. elegans (Greer et al., 2011).
Beyond the genome and the epigenome, cellular aging is
characterized by the accumulation of damaged macromole-
cules, including proteins and lipids, and highly stable aggregates
of those molecules (Campisi and Vijg, 2009). These, too, areCell 148, January 20, 2012 ª2012 Elsevier Inc. 51
manifestations of aging that are also potentially ‘‘reversible,’’
either by dilution in dividing cells or by disaggregation and degra-
dation followedby replacementwith newundamagedmacromol-
ecules. Only mutated and deleted DNA sequences, for which no
template, code, or cellularmachinery exists to guide their correc-
tion, are inaccessible to the rejuvenation process. The notion that
aging is at least in part, if not largely, amanifestation of epigenetic
changes, including those that may be secondary to genomic
mutations, offers a theoretical construct for understanding the
mechanisms of rejuvenation. If so, it should be possible to char-
acterize ‘‘young’’ and ‘‘old’’ cells by specific transcriptional and
epigenetic profiles and states. Furthermore, the processes that
underlie aging and rejuvenation should be identifiable in terms
of regulators of epigenetic states. Although biomarkers of age
have remained elusive, studies have begun to reveal key epige-
netic features of aging cells. We present below some specific
examples of the epigenetic changes identified in aged cells and
the relationship between epigenetic regulators and life span.
Aged cells show several distinctive features on their chromatin
(Figure 2). The CDKN2A (encoding cyclin-dependent kinase
inhibitor p16) locus becomes progressively expressed with
age, eventually leading to cellular senescence, a state of irre-
versible cell-cycle arrest (Krishnamurthy et al., 2004). This mech-
anism may be particularly pronounced in adult tissue stem cells,
which need to undergo long-term self-renewal, especially in the
setting of tissue injury. The CDKN2A locus is under epigenetic
control by the Polycomb group proteins, a gene-silencing
complex. Polycomb-repressive complex 2 (PRC2, with EZH2
being the catalytic subunit) trimethylates lysine 27 of histone
H3 (H3K27me3), which then recruits PRC1 to further modify
the chromatin to enforce gene silencing (Margueron and Rein-
berg, 2011). PRC2 occupies the CDKN2A locus in young cells
and prevents p16 expression. As pancreatic b cells age, EZH2
mRNA and protein levels decline, and the level of H3K27me3
at the CDKN2A locus wanes, now permitting p16 expression
and cell senescence (Dhawan et al., 2009; Dhawan et al.,
2009). Age-related derepression of genes is not entirely passive.
For example, the H3K27me3 demethylase JMJD3 can compete
with EZH2 for occupancy of CDKN2A, erase H3K27me3, and
promote p16 expression. JMJD3 expression is induced by repli-
cative exhaustion and also by the stress-responsive transcrip-
tion factor NF-kB or by oncogenic stress (Agger et al., 2009;
Barradas et al., 2009; De Santa et al., 2007). Interestingly, iPS
experiments suggest that epigenetic features associated with
aging can be reversed. In successfully reprogrammed iPSCs,
the chromatin state of CDKN2A locus associated with aging is
erased and restored to that of youthful cells (Meissner, 2010).
The requirement for proper epigenetic gene silencing for
longevity has been observed in multiple model organisms, sug-
gesting an evolutionarily conserved process (Lin et al., 2000;
Chen et al., 2005; Greer et al., 2010). The function of Polycomb
group proteins is counteracted by the trithorax group proteins,
which encode complexes that trimethylate histone H3 at lysine
4 (H3K4me3), a histone mark associated with gene activation.
In C. elegans, inactivation of several H3K4 methylase subunits
extends life span, whereas inactivation of a H3K4 demethylase
shortens life span (Greer et al., 2010). The specific target genes
of H3K4me3 in worms, presumably causing aging, are not yet52 Cell 148, January 20, 2012 ª2012 Elsevier Inc.clear, but life span extension by trithorax inactivation requires
a functioning germline. Patterns of DNA methylation associated
with gene repression also change with age (Maegawa et al.,
2010; Murgatroyd et al., 2010). Moreover, DNMT1, the enzyme
responsible for maintenance of cytosine methylation, is critical
for theself-renewal of progenitor cells in thebloodandskin (Trow-
bridge et al., 2009; Sen et al., 2010). Depletion of DNMT1 or
enforced expression of Gadd45a, an enzyme involved in a
repair-based mechanism of DNA demethylation, causes epider-
mal stem cell depletion and ectopic differentiation in a manner
analogous to that of Polycomb depletion. However, the exact
genes affected by Polycomb and DNMT1 are more complemen-
tary than overlapping (Sen et al., 2010), indicating that multiple
silencing mechanisms may share common pathways to prevent
ectopic transcription in the aging genome. The observation of
age-associated increase in stochastic gene expression on a
cell-by-cell level (so called transcriptional noise) in some aging
tissues is consistent with this concept (Bahar et al., 2006).
The sirtuin family of NAD+-dependent lysine deacetylases has
long been associated with the control of longevity, although the
precise mechanisms remain controversial (Guarente, 2007;
Vaquero and Reinberg, 2009). As histone acetylation is strongly
associated with gene activation (Wang et al., 2008b), sirtuins are
in general silencers of gene expression by the deacetylation of
histones. In yeast cells, expression of the sirtuin Sir2, which is
required to maintain the silent chromatin state of the ribosomal
RNA genes and telomeres, decreases with replicative age
(Sinclair and Guarente, 1997; Dang et al., 2009). Ectopic tran-
scription and recombination of rRNA genes cause toxicity and
limit replicative life span (Sinclair and Guarente, 1997). Although
initial reports suggested that the overexpression of Sir2 extends
replicative life span in yeast (Kaeberlein et al., 1999) and that
overexpression of sirtuins extends life span of Drosophila and
C. elegans (Tissenbaum and Guarente, 2001; Rogina and
Helfand, 2004), recent evidence suggests that the effects in
Drosophila and C. elegans are minimal and that initial reports
may have been confounded by influences of genetic back-
grounds of the strains (Burnett et al., 2011).
In mammals, seven Sir2 homologs exist and are named Sirt1–
Sirt7. Sirt1 localization is mobile and stress responsive, relocal-
izing to sites of DNA damage where it participates in DNA repair.
But this movement comes at a price: the corresponding depar-
ture of Sirt1 from basal target genes during damage allows these
loci to become derepressed, promoting expression of a number
of genes whose expression is known to increase with age (Ober-
doerffer et al., 2008). This series of events provides one explana-
tion for how environmental stress can indirectly trigger changes
in chromatin state over time. The chromatin-associated sirtuin
Sirt6 is also required for longevity; inactivation of Sirt6 results
in a constellation of defects with features of premature aging
(Mostoslavsky et al., 2006). Sirt6 maintains telomeric chromatin
to promote replicative capacity (Michishita et al., 2008). More-
over, Sirt6 is recruited by transcription factors to target chro-
matin. In particular, Sirt6 directly interacts with NF-kB subunit
RelA and is recruited by RelA to promoters to deacetylate
H3K9Ac, a key event that promotes RelA eviction and terminates
NF-kB signaling (Kawahara et al., 2009). Thus, Sirt6 may provide
a mechanistic link between aging, rejuvenation, and epigenetics
Figure 2. Epigenetic States in Young and Old Cells
Aging is associated with specific changes in chromatin, some of which are illustrated here. In young cells, Polycomb group proteins (PcG) and sirtuins (SIRTs)
silence aging genes by maintaining histone H3 lysine 27 methylation and by deacetylating multiple residues, respectively. Old cells are characterized by the
appearance of DNA damage, which can titrate away sirtuins, as well as stress-inducible transcription factors like NF-kB. An exchange of PcG for Trithorax group
proteins (Trx) and H3K27 demethylase JMJD3 allows accumulation of active chromatin marks such as H3K4me3 and histone acetylation, removal of H3K27me3,
and increased expression of proaging genes such as the cell-cycle inhibitor p16, which drives cell senescence. Additional consequences of epigenetic dys-
regulation include increased transcriptional noise and decreased coordination of gene expression that contributes to organismal aging.(Tennen and Chua, 2011). The connections between aging and
epigenetics are also exemplified by the life span-extending
effects of dietary restriction, which exerts multiple impacts on
chromatin through sirtuins, TOR, and other factors (Vaquero
and Reinberg, 2009).
Clearly, epigenetic changes are both responsive to and effec-
tors of the aging process. With DNA damage and environmental
stresses like inflammation leading to changes in chromatin, the
epigenome clearly adapts to age-related changes in the genome
and the local milieu. Perhaps the epigenome is a general sensor
of cellular dysfunction, sensing metabolic and proteomic
changes that accompany aging as well. However, the epige-
nome is also an effector of the aging process, enforcing different
patterns of gene expression in old cells and young cells and, in
many cases, resulting in cellular phenotypes associated with
aging such as senescence and metaplasia (Martin, 2009). In
that sense, the epigenome is rather like a lens through which
genomic information is filtered (Figure 3), a lens that deteriorates
with age because of both loss of integrity of genomic information
and direct environmental stresses within and outside of the cell.
Within the ‘‘epigenome as lens’’ metaphor, the process of rejuve-
nation is the restoration of a youthful state by actions on the
epigenomic lens (Figure 3). The loss of integrity of the genomic
information remains, but the rejuvenating interventions are suffi-
cient to overcome and possibly reverse at least some of the age-
related epigenetic changes. Similarly, an altered epigenome and
gene expression programs may also be able to reverse or
compensate for some age-dependent biochemical changes,
such as protein aggregation, macromolecular oxidation, and gly-
cation, to maintain cellular functions (Douglas and Dillin, 2010).
Rejuvenation: Is It Epigenetic Reprogramming?
By analogy to the attainment of a pluripotent state by epigenetic
reprogramming of a differentiated cell, is cellular rejuvenation byheterochronic parabiosis, NF-kB inhibition, or inhibition of
mTOR signaling (Figure 1) a form of epigenetic reprogramming
from an aged state to a youthful state? If so, then these would
be examples of an uncoupling of the differentiation program
from the aging clock, with cells in each case manifesting an
apparent rewinding of the aging clock without loss of differenti-
ation. Formal demonstration will require clear epigenetic signa-
tures of young and old cells and evidence that the aged cells
have regained a youthful signature. It should be noted that
reprogramming of the epigenome to a youthful state in an
aged cell has inherent risks and uncertainties. For example, the
increase in proliferative activity of aged stem cells and progeni-
tors by heterochronic parabiosis may increase the risk of devel-
oping malignancies among cells that have acquired genomic
mutations during normal aging but then acquire increased prolif-
erative potential by this rejuvenating intervention. Clearly, any
therapeutic goal of cell or tissue rejuvenation would aim to
restore a ‘‘young adult’’ state from an elderly state, not rewinding
the aging clock back to embryonic or even postnatal develop-
mental stages when growth and morphogenesis are paramount
and the systemicmilieu is very different from that in the adult. The
challenge would be to reset the aging clock back to the appro-
priate adult stage. Another challenge is the coordination of
reprogramming among different cell types in multicellular organ-
isms. As such, the most feasible near-term applications of any
type of rejuvenating intervention for therapeutic purposes would
be those that could be administered in a temporally and spatially
controlled manner (e.g., to a specific site of wound repair or
tissue injury for a limited time).
Studies of cell rejuvenation without dedifferentiation, uncou-
pling the aging clock from the differentiation program, raise
several critical experimental questions that will relate to the
epigenetic mechanisms at play. First, what is the perdurance
of the rejuvenated phenotype once the inducing conditions areCell 148, January 20, 2012 ª2012 Elsevier Inc. 53
Figure 3. Aging and Rejuvenation through the ‘‘Epigenetic Lens’’
The process of light passing through a film, focused by a lens, and projected to
create a complex image is drawn as a metaphor for genetic information being
processed and interpreted by epigenetic mechanisms to create complex
cellular phenotypes. In this analogy, the film represents the genome (shown as
a DNA double helix) containing the fundamental information, the lens repre-
sents the epigenome (represented as a string of nucleosomes) that allows that
genetic information to be translated, and the Cell cover represents the re-
sulting complex phenotype (shown as a mature neuron).
In the vertical axis, the processes first of aging and then of rejuvenation are
illustrated. With age, there is clearly a deterioration of the cellular phenotype,
reflected by a blurring of the image. This may be due to intrinsic changes to
DNA (depicted as double-strand breaks) and also to the epigenome (depicted
as less well-organized nucleosomes), the latter resulting both from genomic
changes and also from environmental influences. Together, these changes
distort the genomic information of youth to create imperfect products, blurred
as an image and structurally and functionally disrupted as a cell. Based on the
ideas put forth in this Review, we postulate that most, if not all, of the reju-
venating effects, such as those that result from processes (e.g., fertilization,
SCNT, iPS cell generation) or interventions (e.g., heterochronic parabiosis,
54 Cell 148, January 20, 2012 ª2012 Elsevier Inc.removed? When the cells are free of the rejuvenating influence,
do they immediately reacquire an aged phenotype, or does the
youthful phenotype persist? In successful iPSC reprogram-
ming, the endogenous embryonic stem cell transcription
factors are stably induced, and the exogenously introduced
factors are not required to sustain iPSCs (Okita et al., 2007).
Is the rejuvenated state also stable after an ‘‘induction’’ period?
Second, is it possible to rejuvenate differentiated cells with
a limited number of transcription factors? As noted above,
induction of the pluripotent state is possible with a very limited
number of transcription factors (Takahashi and Yamanaka,
2006). Similar results have also been obtained for transdifferen-
tiation of fibroblasts into cardiomyocytes by defined transcrip-
tion factors, confirming that stable epigenetic reprogramming
into multiple cell fates is possible with defined factors (Ieda
et al., 2010). Clearly, inhibiting single signaling pathways
(NF-kB and mTOR) is sufficient to restore some features of
youthful cells, but the number of transcriptional regulators
that need to be modulated to result in full rejuvenation is
unknown. Third, is the youthful state or the aged state domi-
nant? It would be interesting to determine which epigenetic
and transcriptional profile is more robust in experiments of
fusion of young and old cells.
Concluding Remarks
Several of the fundamental questions discussed above will be
answered only with more detailed information on the genetic
and epigenetic profiles associated with aging. Clearly, the
establishment of transcriptional networks and epigenetic
profiles for cells from different ages and across species will
reveal the features that are generalizable characteristics of
aging and allow for direct tests of whether it is possible, as
with the relationship between pluripotent and differentiated
states, to directly program a cell to be either young or old
even if only transiently and incompletely. It is interesting that
many of the rejuvenating interventions act on the stem cell
compartments, perhaps reflecting shared genetic and biochem-
ical pathways controlling stem cell function and longevity
(Rando, 2006; Sharpless and DePinho, 2007; Jones and Rando,
2011). Many of the secrets to organismal longevity might, in fact,
be linked to the biology of stem cell quiescence and self-
renewal.
Although genetic and environmental interventions have clearly
proven to be effective in prolonging life span, we postulate that
those interventions, as well as the rejuvenating interventions
described above, are, in fact, acting primarily to modify the
epigenome. Consistent with this, genetic interventions directly
targeting the epigenome can extend life span (Greer et al.,
2010). Studying aging and rejuvenation through the lens of
epigenetics and reprogramming therefore offers a fresh view of
the mysteries of the aging process itself.NF-kB inhibition, mTOR inhibition) described, act by restoring the epigenomic
lens back toward a more youthful state. The resulting image/cell may not be
precisely ‘‘young’’ but has youthfulness restored by these processes and
interventions that act by reprogramming the epigenome. It is thus the epige-
netic lens that is critical for establishing the aged phenotype and that is the
target for rejuvenating interventions and reprogramming that are responsible
for the apparent rewinding of the aging clock.
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